Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-154092
Filing Date
2025-07-01
Accepted
2025-07-01 16:57:00
Documents
13
Period of Report
2025-06-26
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d928306d8ka.htm   iXBRL 8-K/A 28049
2 EX-2.1 d928306dex21.htm EX-2.1 625563
  Complete submission text file 0001193125-25-154092.txt   934851

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tsbx-20250626.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsbx-20250626_lab.xml EX-101.LAB 19443
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsbx-20250626_pre.xml EX-101.PRE 12150
16 EXTRACTED XBRL INSTANCE DOCUMENT d928306d8ka_htm.xml XML 4965
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41747 | Film No.: 251097195
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)